Ritholtz's Reads: Drugs, Facebook and Elon Musk

Barry Ritholtz is a Bloomberg View columnist. He founded Ritholtz Wealth Management and was chief executive and director of equity research at FusionIQ, a quantitative research firm. He blogs at the Big Picture and is the author of “Bailout Nation: How Greed and Easy Money Corrupted Wall Street and Shook the World Economy.”
Read More.
a | A

The days get warmer; let’s see if the markets do as well. Here are our green-jacketed morning train reads:

  • How Come It’s Still Harder to Become a Hairdresser than a Financial Adviser? (MoneyBeat)
  • Trading Costs & The New Market Averages (A Wealth of Common Sense)
  • Active Management Is Far From Dead (EconomPic Data)
  • Cheap Bond Funds Fueled Oil Bubble (Bloomberg Gadfly)
  • The world has too many workers. Here’s one way to fix it. (Wonkblog)
  • We are now witnessing Elon Musk’s slow-motion disruption of the global auto industry (Quartz)
  • The new face of Facebook: The social network has turned itself into one of the world’s most influential technology giants, and wants to become ever more powerful (Economist)
  • Makers took big price increases on widely used U.S. drugs (Reuters)
  • YouTube music terms put labels in a spin (FT)
  • Keeping the sea lanes open: a cost–benefit analysis (Inside Story)

Be sure to check out our new Masters in Business interview with Keith Ross, chief executive officer of PDQ Enterprises, which operates a dark pool, and former CEO of high-frequency trading company Getco.

'Misery Index' at lowest level since 1950s

Source: Brookings

This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.

To contact the author of this story:
Barry Ritholtz at britholtz3@bloomberg.net

To contact the editor responsible for this story:
Zara Kessler at zkessler@bloomberg.net